CDC Scores Poorly on Biosafety

In the wake of numerous safety breaches at the federal agency, a new report finds US Centers for Disease Control and Prevention oversight “inconsistent and insufficient at multiple levels.”

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA“Safety is not integrated into strategic planning and is not currently part of the CDC [US Centers for Disease Control and Prevention] culture, enterprise-wide.” This is the conclusion of a new report evaluating the federal agency’s internal protocols.

The last nine months have been a public relations nightmare for the agency. In two separate incidents last summer, samples of live Bacillus anthracis were accidentally shipped to labs ill-equipped to handle the pathogen, and the CDC’s influenza lab mistakenly sent samples of the highly pathogenic H5N1 to a Department of Agriculture facility (instead of benign avian influenza virus). Then, in late December, another incorrect transfer of samples risked exposing a lab technician to Ebola.

Following these safety breaches, the CDC announced that it would hire a lab safety chief to oversee the handling of such dangerous pathogens, and brought an external work group of 11 biosafety and laboratory science experts in to assess its safety protocols. The group’s report—dated January 13 but just posted ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo